CI Investments Inc. Sells 8,335 Shares of CVS Health Corporation $CVS

CI Investments Inc. reduced its holdings in CVS Health Corporation (NYSE:CVS) by 8.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,603 shares of the pharmacy operator’s stock after selling 8,335 shares during the quarter. CI Investments Inc.’s holdings in CVS Health were worth $6,529,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the business. Harbor Capital Advisors Inc. increased its stake in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares in the last quarter. Corundum Trust Company INC acquired a new stake in CVS Health in the 3rd quarter valued at about $29,000. Front Row Advisors LLC raised its stake in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares during the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in shares of CVS Health during the second quarter worth approximately $36,000. Finally, SOA Wealth Advisors LLC. grew its stake in shares of CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the topic of several research reports. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Wolfe Research cut their price target on CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research note on Monday. Sanford C. Bernstein reiterated a “market perform” rating and issued a $91.00 price objective on shares of CVS Health in a research report on Tuesday, January 6th. The Goldman Sachs Group upped their target price on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.77.

CVS Health Stock Performance

Shares of CVS stock opened at $80.57 on Thursday. The stock has a market cap of $102.50 billion, a PE ratio of 58.38, a price-to-earnings-growth ratio of 0.84 and a beta of 0.49. The stock has a 50-day moving average of $78.53 and a 200-day moving average of $77.50. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. During the same quarter last year, the firm earned $1.19 EPS. CVS Health’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.